Aquamin | more than a calcium. There has been controversy over calcium supplementation in recent years with allegations of possible adverse affects on cardiovascular health. The most recent published trial examining Aquamin highlights some very positive indications in this area, and reinforces the message that Aquamin exists in a different category and is superior to calcium supplements derived from mined minerals. The paper, Cronin et al, reports data from a large-scale study of post-menopausal women (300 subjects) performed at the University of Coleraine in Ireland, and shows that Aquamin and Aquamin+scFOS (prebiotic) both prevented increases in LDL and total cholesterol over 2 years compared to placebo, and data also indicates that there was no increased risk of adverse cardiovascular events associated with long-term supplementation of Aquamin. The paper is published in the British Journal of Nutrition. The Journal has a 2015 impact factor of  3.453, indicating that this is a very reputable source and further strengthens the findings. A copy of the publication can be found by clicking here and a summary from Marigot at the link below. Cronin et al, 2016 Cardiovascular Summary Contact the team at Deltagen to find out more about this study or about Aquamin in general.